News for 'Good Manufacturing Practice'

Quality Control Orders: What does this mean for domestic industry?

Quality Control Orders: What does this mean for domestic industry?

Rediff.com25 Apr 2024

From toys, footwear and furniture to insulated flasks, smart meters, and air coolers - the Central government over the last decade has mandated higher standards for production and imports of such items. Sample this: Till 2014, there were 14 Quality Control Orders (QCOs) covering 106 products. By the latest count, there are 156 QCOs on 672 products.

No advance payments, says Bharat Biotech as Brazil suspends deal

No advance payments, says Bharat Biotech as Brazil suspends deal

Rediff.com30 Jun 2021

"We suspended the deal as a simple preventive measure, since there are complaints that could not be explained well by the complainant, so we opened a preliminary investigation last week," said Rosario, head of the Federal Comptroller General.

'He Was Not An 'I' Man At All'

'He Was Not An 'I' Man At All'

Rediff.com23 Oct 2024

'He was a practical person who ensured that he thought about the common man, animals, the fact that they have a life and they have to be respected.'

How Haryana Win Revives Modi Aura

How Haryana Win Revives Modi Aura

Rediff.com17 Oct 2024

BIf you know this BJP, it will now go forward to Jharkhand and Maharashtra as if June 2024 never happened, notes Shekhar Gupta.

Now, Hospira under US FDA's lens

Now, Hospira under US FDA's lens

Rediff.com23 Dec 2013

Formal warning to Indian unit of deficiencies noted during inspection at facility near Chennai; firm says will remedy

Modi wins 3rd term, but it will be a different NDA now

Modi wins 3rd term, but it will be a different NDA now

Rediff.com4 Jun 2024

Despite the upbeat statement, the party is expected to reflect on what caused the sharp fall in its numbers. It is expected to win about 240 seats against the 303 it had won in 2019.

Ranbaxy whistle-blower to talk on quality of Made-in-India drugs

Ranbaxy whistle-blower to talk on quality of Made-in-India drugs

Rediff.com27 Feb 2014

Whistle-blower Dinesh Thakur will speak on Made-in-India drugs at an event in Washington.

Lapses by some pharma cos overshadowed good things: FDA chief

Lapses by some pharma cos overshadowed good things: FDA chief

Rediff.com12 Feb 2014

On her maiden visit to India, US Food and Drug Administrator Margaret A Hamburg has said recent lapses in quality by a handful of pharma companies has overshadowed the good things done by other Indian companies, who emphasise on quality products and practices.

After ban on drug facilities, US regulator comes calling

After ban on drug facilities, US regulator comes calling

Rediff.com10 Feb 2014

Margaret A Hamburg, the first commissioner of the US Food and Drug Administration (US FDA) to visit India officially, will meet heads of major domestic pharma companies such as Ranbaxy, Wockhardt, Cadila Healthcare and Lupin in New Delhi.

Ranbaxy sets aside Rs 257.4 cr for impact of USFDA ban

Ranbaxy sets aside Rs 257.4 cr for impact of USFDA ban

Rediff.com5 Feb 2014

Pharma major Ranbaxy Laboratories has set aside Rs 257.4 crore (Rs 2.57 billion) towards the financial impact of a US ban on import of products made at its plant at Toansa.

'Aim to make FAME scheme more transparent'

'Aim to make FAME scheme more transparent'

Rediff.com14 Apr 2023

'The aim is also to probe how the ministry and testing agencies made negligence in examining these OEMs, so that such negligence is avoided in the future.'

We will regain confidence of the US FDA: Dilip Shanghvi

We will regain confidence of the US FDA: Dilip Shanghvi

Rediff.com26 Mar 2015

'The focus for value creation will be on all business segments.'

HCL Tech Q4 net profit flat at Rs 3,986 cr

HCL Tech Q4 net profit flat at Rs 3,986 cr

Rediff.com26 Apr 2024

India's third largest IT company HCL Technologies on Friday reported a flat year-on-year growth in net profit in the March quarter at Rs 3,986 crore. However, the company posted an 8.4 per cent decline in net profit on a sequential basis, amid rising employee cost and tightening IT spends around the world. The company described the performance as "decent" in view of the global macroeconomic conditions.

Indian 2 Review: Kamal Haasan Elevates Overwritten Sequel

Indian 2 Review: Kamal Haasan Elevates Overwritten Sequel

Rediff.com12 Jul 2024

The saving grace of Shankar's expanded universe is the masterful precision with which Kamal Haasan drops himself into a messy setup, only slightly to elevate the pulpy tendencies of Shankar's vision, observes Arjun Menon.

Delhi air improves, but still in 'poor' category

Delhi air improves, but still in 'poor' category

Rediff.com24 Oct 2023

The city's average air quality index (AQI) stood at 220 at 12 noon, improving from 263 at 4 pm on Monday.

Ram Teri Ganga Maili

Ram Teri Ganga Maili

Rediff.com12 Jun 2024

Six decades and more later, we are now captives of our identities. Every poll is based on elaborate calculations of electability of candidates on the basis of their castes and other narrow definers. That, along with voter promiscuity, is what defines our political culture, which remains stubbornly resistant to any change, asserts Shreekant Sambrani.

Keep us in loop before any FDA swoop, India tells US

Keep us in loop before any FDA swoop, India tells US

Rediff.com11 Feb 2014

Inspections only in domestic authorities' presence, visiting US drug regulator told

Should you buy refurbished goods online?

Should you buy refurbished goods online?

Rediff.com16 Nov 2015

Price arbitrage for popular products is low but some of these platforms are worth a look for decent deals.

The Most Memorable Goodbye Turns 50

The Most Memorable Goodbye Turns 50

Rediff.com27 Aug 2024

'Garm Hava understands that the scorching, hate-filled, doubt-filled affair between Hindus and Muslims is our national love affair.' Sreehari Nair revisits M S Sathyu's classic film, featuring the incomparable Balraj Sahni at his finest in his final role.

Ranbaxy says its drugs are safe

Ranbaxy says its drugs are safe

Rediff.com14 Jun 2013

Ranbaxy Laboratories on Thursday said it will co-operate fully with any regulator from anywhere in the world wanting to investigate its manufacturing practices.

US threatens to take additional action against 'unfair' Indian trade practices

US threatens to take additional action against 'unfair' Indian trade practices

Rediff.com21 Jun 2019

India has been the single biggest beneficiary of the decades-old US Generalized System of Preferences programme, allowing the country to export $ 5.7 billion worth of duty-free goods in 2017, according to figures from US Congress.

India's Chip Dreams Won't Happen Unless...

India's Chip Dreams Won't Happen Unless...

Rediff.com15 May 2023

OSAT majors have concerns about India's ability to provide a stable, predictable, and lasting policy environment for years to come, which is key for making a decision in a capital-intensive business.

Campus Placements At IITs Getting Tough

Campus Placements At IITs Getting Tough

Rediff.com8 Jul 2024

Nearly 40 per cent of IITians sitting for placements in 2024 are yet to receive job offers, showing a doubling of the 'unplaced' in the last three years from 19 per cent in 2021-2022 to 38 per cent in 2023-2024.

Why Sun Pharma stock will remain under pressure

Why Sun Pharma stock will remain under pressure

Rediff.com24 Dec 2019

The weakness in the stock was because of inspections by the American drug regulator at its Halol plant in Gujarat which resulted in eight observations, as well as a downward revision of speciality drug payoffs.

Before You Invest ESG Funds, Read This

Before You Invest ESG Funds, Read This

Rediff.com19 Mar 2024

An allocation to ESG theme funds can bring down the overall risk of an equity portfolio. Investors with long-term financial goals, such as retirement, should not ignore sustainable investing.

'Ambani, Adani, Tata will move to Dubai if India imposes inheritance tax'

'Ambani, Adani, Tata will move to Dubai if India imposes inheritance tax'

Rediff.com8 May 2024

'Sweden removed the inheritance tax because many of the rich were fleeing. For example, the owner of IKEA had migrated out of Sweden'

Cash crunch pain hits Dharavi's leather goods hub

Cash crunch pain hits Dharavi's leather goods hub

Rediff.com21 Dec 2016

The first of a six-part series examines how the leather workers at Dharavi are coping after five weeks of demonetisation.

US says Covaxin successfully neutralises Delta variant

US says Covaxin successfully neutralises Delta variant

Rediff.com30 Jun 2021

The NIH said results of two studies of blood serum from people who had received Covaxin suggest that the vaccine generates antibodies that effectively neutralise the B.1.1.7 (Alpha) and B.1.617 (Delta) variants of SARS-CoV-2, first identified in the United Kingdom and India, respectively.

As drug firms squirm, authorities look abroad for cure

As drug firms squirm, authorities look abroad for cure

Rediff.com23 Sep 2013

DCGI, health ministry initiate dialogues with foreign regulators, try to understand global best practices

Markets come off two-month highs; Nifty ends below 8,250; IT stocks drag

Markets come off two-month highs; Nifty ends below 8,250; IT stocks drag

Rediff.com6 Jan 2017

The BSE Midcap also cut all its intraday gains to shed 0.3% at close

Toxins in food? How brands can make it safer

Toxins in food? How brands can make it safer

Rediff.com6 Jun 2016

As controversy plagues foods again, brandification will bridge the trust deficit, critical for stakeholders.

Ayurveda with an allopathic twist

Ayurveda with an allopathic twist

Rediff.com2 Dec 2017

Kapiva's plans to introduce allopathy-like doses of ayurvedic remedies for the millennial consumer finds traction.

The battle over product designs

The battle over product designs

Rediff.com25 Jun 2008

With rising consumerism, future feuds will be over the appearance of products.

'Thank goodness drivers bring money'

'Thank goodness drivers bring money'

Rediff.com16 Feb 2018

Williams defended their young and inexperienced Formula One drivers

Sun-Ranbaxy merger may spill over to 2015

Sun-Ranbaxy merger may spill over to 2015

Rediff.com15 Nov 2014

The Competition Commission of India and the US Federal Trade Commission are yet to give their nod to the biggest pharma merger and acquisition deal this year in the Asia-Pacific region.

Cong promises caste survey, interest-free farm loan in Rajasthan manifesto

Cong promises caste survey, interest-free farm loan in Rajasthan manifesto

Rediff.com21 Nov 2023

The party also promised reservation to minorities on basis of their population after the caste census.

At 1.3 million, two-wheeler sales cross pre-Covid figs of September 2019

At 1.3 million, two-wheeler sales cross pre-Covid figs of September 2019

Rediff.com26 Oct 2023

The two-wheeler segment is, however, still far from its H1FY19 peak of 9.7 million units

Integration challenges: Sun Pharma's next hurdle

Integration challenges: Sun Pharma's next hurdle

Rediff.com23 Apr 2015

The challenge of merging Ranbaxy into the company has not been factored in.

Modi reveals names of Gaganyan mission astronauts. They are...

Modi reveals names of Gaganyan mission astronauts. They are...

Rediff.com27 Feb 2024

The four astronauts are -- Prashanth Balakrishnan Nair, Angad Prathap, Ajit Krishnan, and Shubhanshu Shukla -- Modi said at the Vikram Sarabhai Space Centre (VSSC) at Thumba near the Kerala state capital.

How to make GST a Good Simple Tax

How to make GST a Good Simple Tax

Rediff.com21 Nov 2017

'The only way to minimise logical inconsistencies and confusion is to develop the two rates of 12% and 18% as the ones that apply to almost all items.' 'At a later stage, these two rates could be merged into a single rate,' advises T N Ninan.